Urol. praxi. 2024;25(3):139-145 | DOI: 10.36290/uro.2024.058

Acute situations in urology from the point of view of clinical microbiologist

MUDr. Václava Adámková, Ph.D.1, MUDr. Jan Závora1, 2
1 Ústav lékařské chemie a laboratorní diagnostiky, Klinická mikrobiologie a ATB centrum, Univerzita Karlova v Praze, 1. lékařská fakulta a Všeobecná fakultní nemocnice, Praha
2 Ústav mikrobiologie, Univerzita Palackého v Olomouci, Lékařská fakulta, Olomouc

The presented text summarizes the issue of upper urinary tract infections, especially from the perspective of a clinical microbiologist. The basic principles of diagnosis and treatment of urinary tract infections with regard to the current epidemiological situation are presented. Recommendations for antibiotic treatment reflect current European and Czech guidelines.

Keywords: urinary tract infections, cumulative antibiogram, resistance, acute pyelonephritis, urosepsis.

Accepted: October 1, 2024; Published: November 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adámková V, Závora J. Acute situations in urology from the point of view of clinical microbiologist. Urol. praxi. 2024;25(3):139-145. doi: 10.36290/uro.2024.058.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 14.11.2025

    References

    1. Matoušková M, Adámková V, Čedhová V, Lahoda Brodská H. Konsenzuální postupy v léčbě močových infekcí. Olomouc: Solen, 2022.
    2. Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803-812. Go to original source... Go to PubMed...
    3. Crader MF, Kharsa A, Leslie SW. Bacteriuria. 2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
    4. Mandell G, Bennett JE, Dolin R. Principles and practise of infectious diseases. 8 vyd. Philadelphia: Churchill Livingstone, 2015.
    5. Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1-e94. Go to original source... Go to PubMed...
    6. Adámková V. Základy vyšetření v klinické mikrobiologii a interpretace nálezů. In: Lahoda Brodská H, Kohout P (ed.) Laboratorní vyšetření v klinické praxi. Praha: Grada, 2022, p. 250-279.
    7. Barichello T, Generoso JS, Singer M, et al. Biomarkers for sepsis: more than just fever and leukocytosis‑a narrative review. Crit Care. 2022;26(1):14. Go to original source... Go to PubMed...
    8. Lahoda Brodská H, Kohout P (ed.). Laboratorní vyšetření v klinické praxi. Praha: Grada; 2022.
    9. Pogue JM, Kaye KS, Cohen DA, ET AL. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin Microbiol Infect. 2015;21:302-312. Go to original source... Go to PubMed...
    10. Bassetti M, De Waele JJ, Eggimann P, ET AL. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med. 2015;41:776-795. Go to original source... Go to PubMed...
    11. Lepe JA, Martínez-Martínez L. Resistance mechanisms in Gram-negative bacteria. Med Intensiva (Engl Ed). 2022; 46(7):392-402. Go to original source...
    12. Ma J, Song X, Li M, ET AL. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. 2023;266:127249. Go to original source... Go to PubMed...
    13. Moehring RW, Hazen KC, Hawkins MR, ET AL. Challenges in Preparation of Cumulative Antibiogram Reports for Community Hospitals. J Clin Microbiol. 2015;53(9):2977-2982. Go to original source... Go to PubMed...
    14. Adámková V. Návrh standardu pro přípravu kumulativních antibiogramů. Klin Mikrobiol Inf Lék. 2021;27(3): 104-115.
    15. Česká lékařská společnost Jana Evangelisty Purkyně, Subkomise pro antibiotickou politiku (SKAP). Cefalosporiny. Praktický lékař. 2016;96(1):32-50.
    16. McAteer J, Lee JH, Cosgrove SE, ET AL. Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia. Clin Infect Dis. 2023;76(9):1604-1612. Go to original source... Go to PubMed...
    17. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. Go to original source... Go to PubMed...
    18. Qiu X, Lei YP, Zhou RX. SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2023;21(8):891-900. Go to original source... Go to PubMed...
    19. Rello J, van Engelen TSR, Alp E, et al. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2018;24(12):1264-1272. Go to original source... Go to PubMed...
    20. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam, the Netherlands 2022. Arnhem: EAU Guidelines Office, 2022. Dostupné na: http://uroweb.org/guidelines/compilations‑of‑all‑guidelines/.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.